REBECCA KOUMA: Open Payments
NPI 1114705217 · DAVID CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 22 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $378 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Lilly USA, LLC | 9 | $138 |
| Novo Nordisk Inc | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: BREZTRI, JARDIANCE, MOUNJARO, Ozempic, REXULTI, INSPIRE, FARXIGA, AIRSUPRA.
Industry payments across NE — which companies pay providers there.
